Clínica Baviera, S.A.

MSE:CBAV.MC

36.9 (EUR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 224.924198.449172.73122.626124.333109.29499.8891.57285.52782.62179.97689.88193.59389.68383.14187.93778.38263.52743.397
Cost of Revenue 129.93825.50221.48415.25314.68712.83411.33311.7811.60411.3178.4539.90810.3819.5097.6737.8985.8283.4920
Gross Profit 94.986172.948151.246107.372109.64696.45988.54779.79273.92371.30371.52379.97283.21280.17475.46980.03972.55360.03543.397
Gross Profit Ratio 0.4220.8710.8760.8760.8820.8830.8870.8710.8640.8630.8940.890.8890.8940.9080.910.9260.9451
Reseach & Development Expenses 0000.4270.5911.0180.7880.5080.5450000000000
General & Administrative Expenses 15.85218.34414.7919.16610.8959.1988.8577.2317.1416.2336.9557.79700000015.899
Selling & Marketing Expenses 10.3119.8628.4195.7948.227.3047.8936.2875.8225.7215.5387.1680000000
SG&A 45.40428.20623.2114.95919.11616.50216.7513.51812.96311.95512.49314.96400000015.899
Other Expenses 0.459102.62688.57471.90472.13662.97358.17454.66754.42453.71451.15461.30175.17172.54171.44969.28554.25640.378-5.707
Operating Expenses 44.945130.832111.78486.86391.25279.47574.92468.18667.38865.66863.64776.26675.17172.54171.44969.28554.25640.37810.191
Operating Income 50.04141.49239.42920.50918.31816.9813.62611.6066.5125.6267.0440.6038.0897.84.15911.32118.29819.658-14.067
Operating Income Ratio 0.2220.2090.2280.1670.1470.1550.1360.1270.0760.0680.0880.0070.0860.0870.050.1290.2330.309-0.324
Total Other Income Expenses Net -0.373-0.813-0.53-0.323-0.529-0.173-0.199-0.2630.139-0.42-0.264-3.757-0.47-0.747-1.234-1.57-36.196-39.14-0.314
Income Before Tax 49.66840.6838.89920.18617.78916.80713.42711.3436.6515.2066.780.1917.6197.0532.9259.75-17.898-19.483-14.381
Income Before Tax Ratio 0.2210.2050.2250.1650.1430.1540.1340.1240.0780.0630.0850.0020.0810.0790.0350.111-0.228-0.307-0.331
Income Tax Expense 12.91910.53310.9686.0534.8874.8993.5523.3981.8121.2112.0770.8322.2151.8141.0642.9865.8576.8165.002
Net Income 35.97129.51927.3913.94212.79511.8269.777.9144.884.0554.887-0.0885.4045.2391.8617.012-23.666-26.2869.379
Net Income Ratio 0.160.1490.1590.1140.1030.1080.0980.0860.0570.0490.061-0.0010.0580.0580.0220.08-0.302-0.4140.216
EPS 2.211.811.680.860.780.730.60.490.30.250.3-0.0050.330.320.110.43-1.45-1.610.58
EPS Diluted 2.211.811.680.860.780.730.60.490.30.250.3-0.0050.330.320.110.43-1.45-1.610.58
EBITDA 67.02156.96753.52434.26731.721.9518.0216.51412.00610.72512.6749.86814.52814.66411.55117.77822.51322.74-11.129
EBITDA Ratio 0.2980.2870.310.2790.2550.2010.180.180.140.130.1580.110.1550.1640.1390.2020.2870.358-0.256